急性支气管炎应用止咳散加减治疗的临床分析

目的:对急性支气管炎患者采用止咳散加减进行治疗,探讨和分析其治疗的临床效果。方法:将我们此次收治的48例急性支气管炎患者进行随机分组,分成试验组和对照组,每组24例;对照组:对患者使用阿莫西林克拉维酸钾+热毒宁进行治疗;试验组:在对照组治疗的基础上,对患者采用止咳散加减进行治疗。结果:试验组(24例):痊愈20例,占83.3%;好转:3例,占12.5%;无效1例,占4.2%;治疗有效率为95.8%。对照组(24例):痊愈18例,占75.0%;好转:3例,占12.5%;无效3例,占12.5%;治疗有效率为87.5%。试验组的治疗有效率高于对照组,差异显著,具有统计学意义(P<0.05)。并且试验组患者的症状积分和退热情况要明显优于对照组,差异显著,具有统计学意义(P<0.05)。结论:对急性支气管炎患者采用止咳散加减进行治疗,有效地减轻患者的症状,促进患者的康复,具有安全、高效等特点,值得推广。

A clinical analysis of treating acute bronchitis with Zhike San

Objective：To observe clinical effects of Zhike San on treating acute bronchitis. Methods：48 patients were randomly divided into two groups, 24 cases for each. The control group was given Amoxicillin and clavulanate potassium plus Redu Ning;the test group was given Zhike San more. Results：It is 83.3%for cured, 12.5%for effective, 4.2%for invalid;the total efficacy was 95.8%in the test group. In another, it was 75.0%for cured, 12.5%for effective, 12.5%for invalid;the total efficacy was 87.5%;the symptom score and fever cases in the test were better. The difference was statically significant （P〈0.05）. Conclusion：The therapy with Zhike San can relieve symptoms and improve rehabilitation with safety and was worthy of application.